Page last updated: 2024-10-24

carbamazepine epoxide and HIV Infections

carbamazepine epoxide has been researched along with HIV Infections in 1 studies

carbamazepine epoxide: metabolite of carbamazepine; RN given refers to unlabeled cpd
carbamazepine-10,11-epoxide : An epoxide and metabolite of carbamazepine.

HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Research Excerpts

ExcerptRelevanceReference
"Delavirdine is a non-nucleoside reverse transcriptase inhibitor used in combination regimens for the treatment of HIV-1 infection."2.71Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals. ( Dicenzo, R; DiFrancesco, R; Fischl, M; Forrest, A; Friedland, G; Morse, GD; Para, M; Pollard, R; Shelton, M; Smith, PF, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, PF1
Dicenzo, R1
Forrest, A1
Shelton, M1
Friedland, G1
Para, M1
Pollard, R1
Fischl, M1
DiFrancesco, R1
Morse, GD1

Trials

1 trial available for carbamazepine epoxide and HIV Infections

ArticleYear
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals.
    Clinical pharmacokinetics, 2005, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Anti-HIV Agents; Body Weight; Carbamazepine; Delavirdine; Double-Blind Method; Dr

2005